Defendant Name:
Allergan, Inc.
Defendant Type:
Subsidiary of Public Company
Document Reference:
2017-16
Document Details
Legal Case Name
In the Matter of Allergan, Inc.
Document Name
Allergan Paying $15 Million Penalty for Disclosure Failures During Merger Talks
Document Date
17-Jan-2017
Document Format
Administrative Proceeding
Allegation Type
Issuer Reporting and Disclosure
Document Summary
On January 17, 2017 the SEC announced in a press release that Allergan Inc. "has agreed to admit securities law violations and pay a $15 million penalty for disclosure failures in the wake of a hostile takeover bid." According to the SEC: "Allergan failed to disclose in a timely manner its negotiations with potentially friendlier merger partners in the months following a tender offer from Valeant Pharmaceuticals
International and co-bidders in June 2014."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order